TAG ARCHIVE
POSTS TAGGED AS Guardant Health
Liquid Biopsy Outperforms Tissue Biopsy for NSCLC
April 2, 2019 | Terry Sharrer | Posted in Newsletter
Blood testing
In a study of 282 patients with non-small cell lung cancer, a liquid biopsy device (Guardant 360, Redwood City, [MORE]
Comparing Sequencing Platforms Using the Same Tumor Tissue
February 7, 2017 | Terry Sharrer | Posted in Newsletter
Foundation Medicine (Cambridge, MA) and Guardant Health (Redwood City, CA) both have genomic sequencing platforms for genomic cancer. Foundation analyzes [MORE]